期刊文献+

枸橼酸舒芬太尼有关物质HPLC分析方法的优化 被引量:2

Optimization of HPLC Method for Determination of Related Substances of Sufentanil Citrate
下载PDF
导出
摘要 目的:优化枸橼酸舒芬太尼有关物质的HPLC分析方法。方法:以Agilent HC-C18(4.6 mm×250 mm,5μm)色谱柱为固定相,0.13mol.L-1醋酸铵溶液–甲醇–乙腈(31∶45∶24)(用冰醋酸或氨水调节pH值至7.2)为流动相;检测波长为228 nm;流量1.5 mL.min-1。结果:枸橼酸舒芬太尼峰与各杂质峰能得到较好分离,舒芬太尼及其中间体脱苄物、醚化物、丙酰化物的检测限分别为0.36,0.32,0.64,2.80 ng。结论:该方法灵敏度高,专属性强,可用于枸橼酸舒芬太尼的有关物质的检测。 Objective: To Optimize an HPLC method for the determination of related substances of su^entanil sitrate. Methods: The HPLC condition were consisted of an Agilent HC-Cts (4.6 mm × 250 mm,5 μm) column with mobile phase of 0. 13 mol· L- 1 ammonium acetate solution- methanol -aeetonitrile ( 31 : 45 : 24 ) adjusted pH value to 7.2 with acetic acid or ammonia. The flow rate was 1.5ml · min-1and the detection wavelength was at 228nm. Results: Snfentanil citrate peak was completely separa- ted with peaks of impurities. The detection limit of sufentanil and its intermediate of debenzylation , etherification, propionylation were 0.36, 0.32, 0.64, 2.80 ng. Conclusion:The method is sensitive and accurate, and is suitable for the quality control of sufentanil sitrate.
出处 《中国药品标准》 CAS 2013年第2期122-125,共4页 Drug Standards of China
关键词 枸橼酸舒芬太尼 高效液相色谱法 有关物质 sufentanil sitrate HPLC related substances
  • 相关文献

参考文献8

  • 1裴皓,罗爱林.舒芬太尼药理作用与临床应用[J].医药导报,2009,28(11):1482-1485. 被引量:64
  • 2李玉凤.舒芬太尼的临床应用[J].医学综述,2008,14(7):1086-1088. 被引量:20
  • 3Lili Liang, Shanhe Wan, Jinfang Xiao, et al. Rapid UPLC-MS/MS method for the determination of sufentanil in human plasmaand its application in target-controlled infusion system [ J]. Journalof Pharmaceutical and Biomedical Analysis, 2011 (54) :838-844.
  • 4Luca Palleschi, Luca Lucentini, Emanuele Ferretti, et al. Quanti-tative determination of sufentanil in human plasma by liquid chro-matography / tandem mass spectrometry [ J]. Journal of Pharma-ceutical and Biomedical Analysis, 2003 (32) :329 -336.
  • 5罗中华,朱余兵,于翠霞,鲍红光.HPLC法测定人血浆中舒芬太尼的浓度[J].中国药师,2011,14(2):213-215. 被引量:3
  • 6欧洲药典[S].7.0 版.2011:3001-3002.
  • 7国家食品药品监督管理局YBH06742005[S].
  • 8美国药典[S].34 版.2011:4284.

二级参考文献35

共引文献83

同被引文献15

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部